Literature DB >> 21209368

Akt directly regulates focal adhesion kinase through association and serine phosphorylation: implication for pressure-induced colon cancer metastasis.

Shouye Wang1, Marc D Basson.   

Abstract

Although focal adhesion kinase (FAK) is typically considered upstream of Akt, extracellular pressure stimulates cancer cell adhesion via Akt-dependent FAK activation. How Akt regulates FAK is unknown. We studied Akt-FAK interaction in colon cancer cells under 15 mmHg increased extracellular pressure. Pressure enhanced Akt-FAK association, blocked by inhibiting FAK or silencing Akt1 but not Akt2, and stimulated FAK serine phosphorylation in Caco-2 and human colon cancer cells from surgical specimens Akt1-dependently. FAK includes three serine (S517/601/695) and one threonine (T600)-containing consensus sequences for Akt phosphorylation. Studying S->A nonphosphorylatable point mutants suggests that these sites coordinately upregulate FAK Y397 tyrosine phosphorylation, which conventionally initiates FAK activation, and mediate pressure-induced cancer cell adhesion. FAK(T600A) mutation did not prevent pressure-induced FAK(Y397) phosphorylation or adhesion. Akt1 appeared to directly bind FAK, and this binding did not depend on the FAK autophosphorylation site (Y397). In addition, our results demonstrated that Akt phosphorylated FAK at three novel serine phosphorylation sites, which were also not required for FAK-Akt binding. This novel interaction suggests that FAK and Akt may be dual kinase targets to prevent cancer cell adhesion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21209368      PMCID: PMC3063963          DOI: 10.1152/ajpcell.00377.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  57 in total

1.  Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin alphavbeta3.

Authors:  Karen Lawler; Gerardene Meade; Gerald O'Sullivan; Dermot Kenny
Journal:  Am J Physiol Cell Physiol       Date:  2004-07-07       Impact factor: 4.249

Review 2.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

Review 3.  Focal adhesion kinase: a potential target in cancer therapy.

Authors:  Maroesja J van Nimwegen; Bob van de Water
Journal:  Biochem Pharmacol       Date:  2006-09-25       Impact factor: 5.858

4.  FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway.

Authors:  Vijayalakshmi Thamilselvan; David H Craig; Marc D Basson
Journal:  FASEB J       Date:  2007-02-22       Impact factor: 5.191

5.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

Authors:  Vita M Golubovskaya; Carl Nyberg; Min Zheng; Frederick Kweh; Andrew Magis; David Ostrov; William G Cance
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

6.  The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes.

Authors:  Daniel C Berwick; Ingeborg Hers; Kate J Heesom; S Kelly Moule; Jeremy M Tavare
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

7.  TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling.

Authors:  Charles K Thodeti; Benjamin Matthews; Arvind Ravi; Akiko Mammoto; Kaustabh Ghosh; Abigail L Bracha; Donald E Ingber
Journal:  Circ Res       Date:  2009-04-09       Impact factor: 17.367

8.  Insulin-response element-binding protein 1: a novel Akt substrate involved in transcriptional action of insulin.

Authors:  Betty C Villafuerte; Lawrence S Phillips; Madhavi J Rane; Weidong Zhao
Journal:  J Biol Chem       Date:  2004-06-11       Impact factor: 5.157

9.  PDGF and FGF induce focal adhesion kinase (FAK) phosphorylation at Ser-910: dissociation from Tyr-397 phosphorylation and requirement for ERK activation.

Authors:  Isabel Hunger-Glaser; Robert S Fan; Eduardo Perez-Salazar; Enrique Rozengurt
Journal:  J Cell Physiol       Date:  2004-08       Impact factor: 6.384

10.  Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway.

Authors:  Hong Xia; Richard Seonghun Nho; Judy Kahm; Jill Kleidon; Craig A Henke
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

View more
  36 in total

1.  AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.

Authors:  David A Kircher; Kirby A Trombetti; Mark R Silvis; Gennie L Parkman; Grant M Fischer; Stephanie N Angel; Christopher M Stehn; Sean C Strain; Allie H Grossmann; Keith L Duffy; Kenneth M Boucher; Martin McMahon; Michael A Davies; Michelle C Mendoza; Matthew W VanBrocklin; Sheri L Holmen
Journal:  Mol Cancer Res       Date:  2019-05-28       Impact factor: 5.852

2.  Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancer.

Authors:  Po-Kai Chuang; Michael Hsiao; Tsui-Ling Hsu; Chuan-Fa Chang; Chung-Yi Wu; Bo-Rui Chen; Han-Wen Huang; Kuo-Shiang Liao; Chen-Chun Chen; Chi-Long Chen; Shun-Min Yang; Chiung Wen Kuo; Peilin Chen; Ping-Tzu Chiu; I-Ju Chen; Jiann-Shiun Lai; Cheng-Der Tony Yu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

3.  Fibroblast engraftment in the decellularized mouse lung occurs via a β1-integrin-dependent, FAK-dependent pathway that is mediated by ERK and opposed by AKT.

Authors:  Huanxing Sun; Elizabeth Calle; Xiaosong Chen; Aditi Mathur; Yangyang Zhu; Julio Mendez; Liping Zhao; Laura Niklason; Xueyan Peng; Hong Peng; Erica L Herzog
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-13       Impact factor: 5.464

4.  ZINC4085554 inhibits cancer cell adhesion by interfering with the interaction of Akt1 and FAK.

Authors:  Shyam K More; Emilie E Vomhof-Dekrey; Marc D Basson
Journal:  Oncol Lett       Date:  2019-03-27       Impact factor: 2.967

5.  CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.

Authors:  Dan Wu; Xinyi Guo; Jing Su; Ruoying Chen; Dmitriy Berenzon; Martin Guthold; Keith Bonin; Weiling Zhao; Xiaobo Zhou
Journal:  Biochim Biophys Acta       Date:  2014-11-21

6.  Optimization of Protein-Protein Interaction Measurements for Drug Discovery Using AFM Force Spectroscopy.

Authors:  Yongliang Yang; Bixi Zeng; Zhiyong Sun; Amir Monemian Esfahani; Jing Hou; Nian-Dong Jiao; Lianqing Liu; Liangliang Chen; Marc D Basson; Lixin Dong; Ruiguo Yang; Ning Xi
Journal:  IEEE Trans Nanotechnol       Date:  2019-05-14       Impact factor: 2.570

Review 7.  Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics.

Authors:  William G Cance; Elena Kurenova; Timothy Marlowe; Vita Golubovskaya
Journal:  Sci Signal       Date:  2013-03-26       Impact factor: 8.192

Review 8.  Cell survival and metastasis regulation by Akt signaling in colorectal cancer.

Authors:  Ekta Agarwal; Michael G Brattain; Sanjib Chowdhury
Journal:  Cell Signal       Date:  2013-04-18       Impact factor: 4.315

9.  GIV/Girdin (Gα-interacting, Vesicle-associated Protein/Girdin) Creates a Positive Feedback Loop That Potentiates Outside-in Integrin Signaling in Cancer Cells.

Authors:  Anthony Leyme; Arthur Marivin; Mikel Garcia-Marcos
Journal:  J Biol Chem       Date:  2016-02-17       Impact factor: 5.157

10.  Serum metabolomic profile as a means to distinguish stage of colorectal cancer.

Authors:  Farshad Farshidfar; Aalim M Weljie; Karen Kopciuk; W Don Buie; Anthony Maclean; Elijah Dixon; Francis R Sutherland; Andrea Molckovsky; Hans J Vogel; Oliver F Bathe
Journal:  Genome Med       Date:  2012-05-14       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.